Engineering a New Class of Medicines
Codiak is engineering exosomes – nature’s intercellular messengers – to advance an entirely new class of medicines, exosome therapeutics. Through our proprietary engEx™ Platform for engineering and manufacturing, we purpose-build each exosome therapeutic candidate, allowing for enhanced therapeutic targeting and unlocking the potential of this modality to transform the treatment of a wide spectrum of diseases with high unmet medical need.
Leveraging our unparalleled understanding of exosome biology and with emphasis on scientific rigor, we are building a robust pipeline with an initial focus on oncology and neurology.
Pipeline
Leveraging our unparalleled understanding of exosome biology and with emphasis on scientific rigor, we are building a robust pipeline with an initial focus on oncology and neurology.
Pipeline
Codiak’s Vision
Our vision is to make precision exosome therapeutics a reality.
exoASO-STAT6
Our team explains the promise and preclinical profile of our third therapeutic candidate
Understanding Exosomes
Learn how nature’s intercellular messages could be the next therapeutic revolution.
Purpose Driven Science
Rigorous science requires an extraordinary team. With a focus on world-class research, technological innovation, and passion for breaking boundaries, our people embody our mission to bring revolutionary medicines to patients. See what makes the Codiak team so special.
Working at Codiak